Differential binding of viral peptides to HLA-A2 alleles. Implications for human papillomavirus type 16 E7 peptide-based vaccination against cervical carcinoma

European Journal of Immunology

Volumn 29, Issue 4, 1999, Pages 1292-1303

  Ressing, Maaike E ^a   De Jong, Joan H ^a   Brandt, Remco M P ^a   Drijfhout, Jan Wouter ^a   Benckhuijsen, Willemien E ^a   Schreuder, Geziena M T ^a   Offringa, Rienk ^a   Kast, W Martin ^b   Melief, Cornelis J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

HLA A2 supertype; Human papillomavirus type 16; Peptide binding; Peptide vaccination

Indexed keywords

CANCER VACCINE; HLA A2 ANTIGEN; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B VIRUS; HLA SYSTEM; HUMAN; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; VACCINATION; WART VIRUS;

EID: 0032954943     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199904)29:04<1292::AID-IMMU1292>3.0.CO;2-6     Document Type: Article

References (46)

1. Melief, C. J. M., Offringa, R., Toes, R. E. M. and Kast, W. M., Peptide-based cancer vaccines. Curr. Opin. Immunol. 1996. 8: 651-657.
2. Imanishi, I., Akaza, T., Kimura, A., Tokunaga, K. and Gojobori, T., Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In Tsuji, K. Aizawa, M. and Sasazuki, T. (Eds.) HLA 1991. Proceedings of the eleventh international histocompatibility workshop and conference. Oxford University Press, Oxford 1992, pp 1065-1220.
3. Krausa, P., Brywka III, M., Savage, D., Hui, K. M., Bunce, M., Ngai, J. L. F., Teo, D. L. T., Ong, Y. W., Barouch, D., Allsop, C. E. M., Hill, A. V. S., McMichael, A. J., Bodmer, J. G. and Browning, M. J., Genetic polymorphisms within HLA-A(black star sign)02: significant allelic variation revealed in different populations. Tissue Antigens 1995. 45: 223-231.
4. Browning M. and Krausa, P., Genetic diversity of HLA-A2: evolutionary and functional significance, Immunol. Today 1996. 17: 165-170.
5. Rammensee, H. G., Bachmann, J. and Stevanovic, S., (Eds)., MHC ligands and peptide motifs. Chapter 3, the structure. Landes Bioscience, Austin 1997, pp 141-216.
6. Castano, A. R. and Lopez de Castro, J. A., Structure of the HLA-A(black star sign)0204 antigen, found in South American Indians. Spatial clustering of HLA-A2 subtype polymorphism. Immunogenetics 1991. 34: 281-285.
7. Phillips, R. E., Rowland-Jones, S., Nixon, D. F., Gotch, F. M., Edwards, J. P., Ogunlesi, A. O., Elvin, J. G., Rothbard, J. A., Bangham, C. R., Rizza, C. R. and McMichael, A. J., Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 1991. 354: 453-459.
8. Hill, A. V. S., Elvin, J., Willis, A. C., Aidoo, M., Allsopp, C. E., Gotch, F. M., Gao, X H., Takaguchi, M., Greenwoods, B. M. and Townsend, A. R., Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 1992. 360: 434-439.
9. + population. Science 1993. 260: 98-100.
10. Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L. and Wiley, D. C., Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987. 329: 506-512.
11. Saper, M. A., Bjorkman, P. J. and Wiley, D. C., Refined structure of the human histocompatibility antigen HLA-A2 at 26Å resolution. J. Mol. Biol. 1991. 219: 277-319.
12. Madden, D. R., Garboczi, D. N. and Wiley, D. C., The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 1993. 75: 693-708.
13. Falk, K., Rötzschke, O., Stevanovic, S., Jung, G. and Rammensee, H. G., Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991. 351: 290-296.
14. Rammensee, H. G., Bachmann, J. and Stevanovic, S., (Eds.) MHC ligands and peptide motifs. Chapter 4, the function. Landes Bioscience, Austin 1997, pp 217-370.
15. Del Guercio, M. F., Sidney, J., Hermanson, G., Perez, C., Grey, H. M., Kubo, R. T. and Sette, A., Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J. Immunol. 1995. 154: 685-693.
16. Sidney, J., Grey, H. M., Kubo, R. T. and Sette, A., Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunol. Today 1996. 17: 261-266.
17. + cytotoxic T cell line. J. Immunol. 1996. 157: 787-797.
18. Rivoltini, L., Loftus, D. J., Barracchini, K., Arienti, F., Mazzocchi, A., Biddison, W. E., Salgaller, M. L., Appella, E., Parmiani, G. and Marincola, F. M., Binding and presentation of peptides derived from melanoma antigens MART-1 and glycoprotein-100 by HLA-A2 subtypes. Implications for peptide-based immunotherapy. J. Immunol. 1996. 156: 3882-3891.
19. Sidney, J., Del Guercio, M. F., Southwood, S., Hermanson, G., Maewal, A., Appella, E. and Sette, A., The HLA-A(black star sign)0207 peptide binding repertoire is limited to a subset of the A(black star sign)0201 repertoire. Hum. Immunol. 1997. 58: 12-20.
20. Sette, A. and Sidney, J., HLA supertypes and supermotifs: a functional perspective on HLA polymorphism. Curr. Opin. Immunol. 1998. 10: 478-482.
21. Parkin, D. M., Pisani, P. and Ferlay, J., Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer 1993. 54: 594-606.
22. Bosch, F. X., Manos, M. M., Munoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R. and Shah, K. V., Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 1995. 87: 796-802.
23. Ressing, M. E., Sette, A., Brandt, R. M. P., Ruppert, J., Wentworth, P. A., Hartman, M., Oseroff, C., Grey, H. M., Melief, C. J. M. and Kast, W. M., Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A(black star sign)0201-binding peptides. J. Immunol. 1995. 154: 5934-5943.
24. Ressing, M. E., Van Driel, W. J., Celis, E., Sette, A., Brandt, R. M. P., Hartman, M., Anholts, J. D. H., Schreuder, G. M. T., Ter Harmsel, W. B., Fleuren, G. J., Trimbos, B. J., Kast, W. M. and Melief, C. J. M., Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16-positive cervical lesions against a human leukocyte antigen-A(black star sign)0201-restricted E7-encoded epitope. Cancer Res. 1996. 56: 582-588.
25. Evans, E. M., Man, S., Evans, A. S. and Borysiewicz, L. K., Infiltration of cervical cancer tissue with human papillomavirus-specific cytotoxic T-lymphocytes. Cancer Res. 1997. 57: 2943-2950.
26. Kast, W. M., Brandt, R. M. P., Drijfhout, J. W. and Melief, C. J. M., Human leukocyte antigen-A2.1 restricted candidate cytotoxic T lymphocyte epitopes of human papillomavirus type 16 E6 and E7 proteins identified by using the processing-defective human cell line T2. J. Immunother. 1993. 14: 115-120.
27. Kast, W. M., Brandt, R. M. P., Sidney, J., Drijfhout, J. W., Kubo, R. T., Grey, H. M., Melief, C. J. M. and Sette, A., Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. J. Immunol. 1994. 152: 3904-3912.
28. Sette, A., Sidney, J., Del Guercio, M. F., Southwood, S., Ruppert, J., Grey, H. M. and Kubo, R. T., Peptide binding to the most frequent HLA-A class I alleles measured by quantative molecular binding assays. Mol. Immunol. 1994. 31: 813-822.
29. Van der Burg, S. H., Ras, E., Drijfhout, J. W., Benckhuijsen, W. E., Bremers, A. J. A., Melief, C. J. M. and Kast, W. M., An HLA class I peptide-binding assay based on competition for binding to class I molecules on intact human B cells. Identification of conserved HIV-1 polymerase peptides binding to HLA-A(black star sign)(black star sign)(black star sign)(black star sign)0301. Hum. Immunol. 1995. 44: 189-198.
30. Van der Burg, S. H., Visseren, M. J. W., Brandt, R. M. P., Kast, W. M. and Melief, C. J. M., Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. J. Immunol. 1996. 156: 3308-3314.
31. Barouch, D., Friede, T., Stevanovic, S., Tussey, L., Smith, K., Rowland-Jones, S., Braud, V., McMichael, A. and Rammensee, H. G., HLA-A2 subtypes are functionally distinct in peptide binding and presentation. J. Exp. Med. 1995. 182: 1847-1856.
32. Feltkamp, M. C. W., Vierboom, M. P. M., Kast, W. M. and Melief, C. J. M., Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity. Mol. Immunol. 1994. 31: 1391-1401.
33. Sette, A., Vitiello, A., Reherman, B., Fowler, P., Nayersina, R., Kast, W. M., Melief, C. J. M., Oseroff, C., Yuan, L., Ruppert, J., Sidney, J., Del Guercio, M. F., Southwood, S., Kubo, R. T., Chesnut, R. W., Grey, H. M. and Chisari, F. V., The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 1994. 153: 5586-5592.
34. Arnold, D., Faath, S., Rammensee, H. G. and Schild, H., Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J. Exp. Med. 1995. 182: 885-889.
35. Nieland, T. J. F., Tan, M. C. A. A., Monne-van Muijen, M., Koning, F., Kruisbeek, A. M. and Van Bleek, G. M., Isolation of an immunodominant viral peptide that is endogenously bound to the stress protein GP96/ GRP94. Proc. Natl. Acad. Sci. USA 1996. 93: 6135-6139.
36. Lee, S. P., Tierney, R. J., Thomas, W. A., Brooks, J. M. and Rickinson, A. B., Conserved CTL epitopes within EBV latent membrane protein 2. A potential target for CTL-based tumor therapy. J. Immunol. 1997. 158: 3325-3334.
37. Steller, M., Gurski, K., Murakami, M., Daniel, R., Shah, K., Celis, E., Sette, A., Trimble, E., Park, R. and Marincola, F., Cell-mediated immunological responses in cervical and vaginal cancer patients immunized with a lipidated epitope of human papillomavirus type 16 E7. Clin. Cancer Res. 1998. 4: 2103-2109.
38. Doolan, D. L., Hoffman, S. L., Southwood, S., Wentworth, P. A., Sidney, J., Chesnut, R. W., Keogh, E., Appella, E., Nutman, T. B., Lal, A. A., Gordon, D. M., Oloo, A. and Sette, A., Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity 1997. 7: 97-112.
39. Bertoni, R., Sidney, J., Fowler, P., Chesnut, R. W., Chisari, F. V. and Sette, A., Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J. Clin. Invest. 1997. 100: 503-513.
40. Khanna, R., Borrows, S. R., Nicholls, J. and Poulsen, L. M., Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes. Eur. J. Immunol. 1998. 28: 451-458.
41. Borysiewicz, L. K., Fiander, A., Nimako, M., Man, S., Wilkinson, G. W. G., Westmoreland, D., Evans, A. S., Adams, M., Stacey, S. N., Boursnell, M. E. G., Rutherford, E., Hickling, J. K. and Inglis, S. C., A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer. Lancet 1996. 347: 1523-1527.
42. Barnstable, C. J., Bodmer, W. F., Brown, G., Galfre, G., Milstein, C., Williams, A. F. and Ziegler, A., Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell 1978. 14: 9-20.
43. Berger, A. E., Davis, J. E. and Cresswell, P., Monoclonal antibody to HLA-A3. Hybridoma 1982. 1: 87-90.
44. Parham, P. and Brodsky, F. M., Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28. Hum. Immunol. 1981, 3: 277-299.
45. McMichael, A. J., Parham, P., Rust, N. and Brodsky, F., A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17. Hum. Immunol. 1980. 1: 121-129.
46. Brouwenstijn, N., Hoogstraten, C., Verdegaal, E. M. E., Van der Spek, C. W., Deckers, J. G. M., Mulder, A., Osanto, S. and Schrier, P. I., Definition of unique and shared T-cell defined tumor antigens in human renal cell carcinoma. J. Immunother. 1998. 21: 427-434.